Image For Activity Cover
Denosumab Discontinuation
Presentations/Presenters
Denosumab Discontinuation
Presenter: Bente Langdahl, MD, PhD, DMSc (Aarhus University Hospital)
Relationship: Commercial Interest(s)
  Advisory Board Member: Amgen Inc
  Advisory Board Member: Other (fill in the blank below)
  Advisory Board Member: UCB, Gedeon-Richter
  Speaker: AstraZeneca
  Speaker: Other (fill in the blank below)
  Speaker: UCB, Gedeon-Richter, Astellas
  Grant Recipient: Amgen Inc
  Grant Recipient: Novo Nordisk
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
0.75 AMA PRA Category 1 Credit
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By